A federal advisory panel on Monday recommended Medicare scrap a proposal that would slash drug payments to hospitals under the 340B drug pricing program by almost 30 percentage points next year. But it's worth noting that panel is made up [...]
A panel that advises HHS on outpatient hospital payments wants the CMS to drop a draft rule that could cut up to $1.65 billion out of the 340B discount drug program. On Monday, the Advisory Panel on Hospital Outpatient Payment [...]
When researchers reported earlier this year that colorectal cancer rates were rising in adults as young as their 20s and 30s, some scientists were skeptical. The spike in figures, they suggested, might not reflect a real increase in disease incidence [...]
Background In the United States, prices for therapeutically similar drugs vary widely, which has prompted efforts by public and private insurers to steer patients toward the lower-priced options. Under reference pricing, the insurer or employer establishes a maximum contribution it [...]
Amazon is speeding its efforts to crack the health care market, hiring a number of high-profile executives, testing Echo technology in top hospitals and creating a secret "1492" team dedicated to health-technology opportunities like telemedicine and electronic medical records. Read [...]
As Community Oncology Clinics Threatened, Cancer Patients, Survivors Form CPAN Chapter to Speak Out Scarborough, Maine – On August 17, 2017, New England Cancer Specialists in Scarborough will launch a new local chapter of the Community Oncology Alliance Patient [...]
A rule that would set new ceiling prices in the 340B drug discount program has been delayed until July 2018, HHS announced Thursday. The rule, which was supposed to take effect in April would also authorize HHS to levy fines against drug manufacturers that intentionally [...]
Charity-care reporting requirements under the healthcare reform law may have gone into effect only last October, but already one hospital has lost its not-for-profit tax status as a result. Read the full article on Healthcare Financial Management Association (HFMA) here.
Thousand Oaks biotechnology giant Amgen announced a collaboration agreement with Louisville, Ky.-based Humana on Aug. 17 to study conditions like cardiovascular disease, osteoporosis, neurologic disorders, inflammatory diseases and cancer. Read the full article on Pacific Coast Business Times here.